Minnesota-based Cardiovascular Systems (NSDQ:CSII) landed FDA clearance for a new size of its Diamondback 360 atherectomy system, used in treatment of peripheral artery disease.
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Edwards Lifesciences announces 1st Fortis mitral valve implants
Edwards Lifesciences (NYSE:EW) said a surgical team at London’s St. Thomas’ Hospital implanted the 1st 3 patients with its Fortis transcatheter mitral valve implant.
Priceline founder: The world’s next Facebooks will be healthcare companies
Jay Walker made his fortune in the world of high tech with internet plays such as Priceline.com, which he founded in 1998 and took public a year later, but the man once dubbed "An Edison of the New Age" by Forbes magazine sees the next big things coming from healthcare.
"What happened in the data processing world is coming to medicine," he told an audience of health care executives in New York this week. "There’s no question that the Facebooks of tomorrow are going to be in healthcare."
Europe spikes Edwards Lifesciences’ TAVI patent in war with Medtronic
Medtronic, Abbott land 1st contracts with healthcare coalition SharedClarity
Volcano loses round in FFR war with St. Jude Medical
Cardiovascular Systems touts 1-year outcomes, cost savings for Diamondback 360
Minnesota-based Cardiovascular Systems (NSDQ:CSII) this week unveiled 1-year outcomes of a pivotal study of its Diamondback 360 device in treating coronary artery disease.